Research pinpoints powerful biomarker of Multiple Sclerosis

University of Sydney research in Nature Scientific Reports has found unique molecules in the blood of MS patients could lead to the development of a definitive biomarker diagnosis. A breakthrough study led by the University of Sydney’s Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world’s most common neurologic disability in young adults.

Study uncovers markers for severe form of multiple sclerosis

Scientists have uncovered two closely related cytokines — molecules involved in cell communication and movement — that may explain why some people develop progressive multiple sclerosis (MS), the most severe form of the disease. The findings, authored by researchers at Yale University, Oregon Health & Science University, and the University of California point the way toward developing a novel treatment to prevent progressive forms of the disease.